Navigation Links
New study calculates millions of years saved in lives of AIDS patients

This year, the U.S. federal government will spend $21 billion for HIV/AIDS research, treatment, prevention, and related activities. Is this enormous expenditure paying off? A study published in the July 1 issue of The Journal of Infectious Diseases, now available online, indicates that it is--and more so than previously thought.

The study, by Rochelle P. Walensky, MD, MPH, Kenneth Freedberg , MD, MSc and colleagues at Massachusetts General Hospital and other centers appears at a time the world contemplates the 25-year anniversary of the first reported cases of AIDS and celebrates the 10-year anniversary of the use of multi-drug antiretroviral combinations for the treatment of HIV infections (also known as highly active antiretroviral therapy or HAART).

To analyze the impact of HAART on patient survival, the investigators used a computer simulation model to examine national surveillance and efficacy data for newly diagnosed adult AIDS patients under care in the United States from 1989 to 2003. They divided those years into "eras" corresponding to specific advances in AIDS care, and then used the simulation model to determine per-person survival time for each era, compared to the absence of treatment.

The results: Per-person survival increased by three months in 1989-92 and then by two years in 1993-95; both eras were characterized by the introduction of certain measures to prevent opportunistic infections. But in the four HAART eras spanning 1996 to 2003, per-person survival increased by approximately eight, 11, 12, and 13 years. Over the past 10 years, the investigators concluded, widespread adoption of HAART regimens, in addition to prophylaxis, led to at least 3 million years of life saved in the United States. Moreover, since approximately 25 percent of those infected with HIV in the United States are estimated to be unaware of their infection and little more than half of those who are aware of it are actually in care, Dr. Walensky and cow
'"/>

Source:Infectious Diseases Society of America


Page: 1 2

Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. A new study examines how shared pathogens affect host populations
11. NYU study reveals how brains immune system fights viral encephalitis

Post Your Comments:
(Date:11/30/2009)... inaugural Global Conference on Systems & Enterpri...ington, DC, focuses on the convergence of complex ...portance to society. , The goal of the confe... around targeted complex systems, examined by doma...des Critical Infrastructure Systems, including Int...
(Date:11/30/2009)...es continue to rise scientists are presented with ... respond and adapt. In a paper published in Insec...uez-Trelles and Dr Miguel Rodriguez assess this ch...pproximately 0.6˚C has already affected the E...ologists and evolutionary biologists is to predict...
(Date:11/30/2009)...HIV research is the virus,s exquisite specialisati...aditional tools, like the humble lab mouse, can de...earchers writing in BioMed Central,s open access ... on this problem by creating a mouse that has key ...ith HIV. , George Kassiotis, from the Division o...
Breaking Biology News(10 mins):First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2How can scientists measure evolutionary responses to climate change? 2A reductionist approach to HIV research 2Scientists find molecular trigger that helps prevent aging and disease 61643 1Scientists find molecular trigger that helps prevent aging and disease 61643 2Scientists find molecular trigger that helps prevent aging and disease 61643 3UCLA researchers create fly paper to capture circulating cancer cells 61641 1UCLA researchers create fly paper to capture circulating cancer cells 61641 2UCLA researchers create fly paper to capture circulating cancer cells 61641 3UCLA study shows brains ability to reorganize 61639 1UCLA study shows brains ability to reorganize 61639 2UCLA study shows brains ability to reorganize 61639 3
...rned where and how some plant seeds store iron, a ...ve the iron content of plants. Their research help... and malnutrition in humans. , The team found that...of the seed of Arabidopsis, a model plant used in ...uole, a plant cell,s central storage site. The res...
...ester researchers are recruiting people with backa...ciatica ?in the first ever study to discover if th...r Christopher McCarthy and his team at the Univers...lunteers aged 22-55 who have had sciatica for less...previous spinal surgery. , The volunteers will ...
...aluated improvements in the end-of-life care in in...dings in a special supplement to Critical Care Med... Medicine. The supplement is dedicated entirely to..."Improving the quality of care received by critica...ngoing challenge," explains guest co-editor J. Ran...
Other Biology News:Plant studies reveal how, where seeds store iron 2End-of-life care can be improved 2End-of-life care can be improved 3
(Date:11/30/2009)...ILLE, Md., Nov. 30 Novav... company, announced today that the company will be...nce 2009 on December 2, 2009 at 12:30 pm local tim...provide an overview of the company,s business stra...ng milestones. A link to the live audio only pres...
(Date:11/30/2009)..., Nov. 30 Dr. Jessica Torrente, As...n University Medical Center in Washington, D.C., d...ific Gamma Imaging (BSGI) in clinical practice as ...reast cancer today at the annual meeting of the Ra..."The purpose of the exhibit was to demonstrate how...
(Date:11/30/2009)... Calif., Nov. 30 BioMari...oday that the Food and Drug Administration (FDA) h...pyridine (3,4-DAP), amifampridine phosphate, for t...c Syndrome (LEMS). 3,4-DAP has previously receive...tober 2009, the Committee for Medicinal Products f...
(Date:11/30/2009)...ON and COPENHAGEN, Nov. 30 Exiqon ... that the Harvard Medical School ICCB-Longwood Scr...MicroRNA Screening Center of Excellence. ICCB-L s...nd associated hospitals and institutions, for high...ibraries. ,, MicroRNAs are a novel class of sma...
Breaking Biology Technology:NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3
...HESTER, England, February 5 Epistem plc,(LSE:EHP)...d a preliminary,study with AstraZeneca for the use...man hair biomarker technology to help steer oncolo...sing gene expression change in,RNA extracted from ...human,plucked hair. Changes in gene expression can...
...AMBRIDGE, Mass.-- Researchers at MIT and Texas Ins...ble electronics that can be up to 10 times more en... could lead to cell phones, implantable medical de...g from a battery. , The innovative design will be... Circuits Conference in San Francisco by Joyce Kwo...
...CK, Mass., Feb. 4 Boston Scientific,Corporation (... the fourth,quarter and full year ended December 3...nings per share (EPS) for the first quarter of 200...usted EPS of $0.24 and record net sales of $2.152 ...uidance -- Grew cardiac rhythm management (CRM) s...
Other Biology Technology:Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development 2Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development 3Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development 4Team develops energy-efficient microchip 2Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 2Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 3Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 4Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 5Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 6Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 7Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 8Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 9Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 10Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 11Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 12Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 13Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 14Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 15Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 16Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 17Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 18Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 19Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 20Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 21Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 22Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 23Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 24Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 25Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 26Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 27Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 28Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007 29
GIBCO Dulbeccos Phosphate-Buffered Saline (D-PBS) (1X); liquid Contains calcium and magnesium from Invitrogen
Mouse Anti-JNK2 Antibody, Unconjugated from Upstate
...Immunogen: Synthetic peptide derived from the inte...ty: Specific for the internal region of the MUC5B...t band at ~590 kDa. Reactivity: Human (positive ...ry tracheobranchial epithelial cultures and deglyc...
Latex Gloves, PF- small from Santa Cruz Biotechnology, Inc.
Biology Products: